The Medical University of South Carolina is expanding its access to state-supported Sickle Cell programs for “warriors,” or ...
Fulcrum Therapeutics' promising treatment for Sickle Cell Disease and their strong financial position, despite setbacks.
With the addition of Casgevy, Children’s Hospital Los Angeles now offers two gene therapies for sickle cell, the first being Lyfgenia.
A cutting-edge gene therapy has been approved for NHS use for some patients with severe sickle cell disease. Casgevy, also known as exa-cel, was the first treatment to be licensed using gene ...
In summary, our results demonstrate a role of endothelial Aquaporins in promoting water influx to increase endothelial tip cell volume and cytoplasmic hydrostatic pressure, as well as accelerate actin ...
Sickle cell anaemia, a hereditary condition that primarily affects African and Mediterranean populations, continues to pose significant health challenges. In Uganda, where the disease is prevalent ...
Nanoyang Group, Tianjin Key Laboratory of Advanced Carbon and Electrochemical Energy Storage, School of Chemical Engineering and Technology, National Industry-Education Integration Platform of Energy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results